A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Phase 2 Completed
107 enrolled 17 charts
RP-6306 in Patients With Advanced Cancer
Phase 2 Completed
28 enrolled
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer
Phase 2 Completed
10 enrolled 13 charts
Pancreas
Phase 2 Completed
130 enrolled
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Phase 2 Completed
34 enrolled 12 charts
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer
Phase 2 Completed
23 enrolled 15 charts
PINBALL
Phase 2 Completed
27 enrolled
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)
Phase 2 Completed
10 enrolled 8 charts
NIFE
Phase 2 Completed
93 enrolled
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Phase 2 Completed
74 enrolled
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
Phase 2 Completed
40 enrolled
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor
Phase 2 Completed
14 enrolled
KEYVIBE-005
Phase 2 Completed
613 enrolled
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Phase 2 Completed
57 enrolled
Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer
Phase 2 Completed
2 enrolled 10 charts
A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer
Phase 2 Completed
194 enrolled
Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine
Phase 2 Completed
71 enrolled
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
Phase 2 Completed
32 enrolled 12 charts
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
Phase 2 Completed
45 enrolled
PLATINUM
Phase 2 Completed
152 enrolled
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
Phase 2 Completed
48 enrolled 13 charts
FUNGEMAX
Phase 2 Completed
288 enrolled
EUDARIO
Phase 2 Completed
122 enrolled 23 charts
Adaptive Therapy for Post-Second-Line Advanced Breast Cancer
Phase 2 Completed
10 enrolled
VIRAGE
Phase 2 Completed
112 enrolled
BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients
Phase 2 Completed
45 enrolled 14 charts
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
Phase 2 Completed
55 enrolled
Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Phase 2 Completed
83 enrolled 11 charts
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Phase 2 Completed
139 enrolled 14 charts
RAMES
Phase 2 Completed
164 enrolled
A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma
Phase 2 Completed
28 enrolled
Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer
Phase 2 Completed
87 enrolled 13 charts
ADAPT
Phase 2 Completed
336 enrolled
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
Phase 2 Completed
31 enrolled 8 charts
Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Phase 2 Completed
44 enrolled
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer
Phase 2 Completed
120 enrolled
BURGUND
Phase 2 Completed
115 enrolled
A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers
Phase 2 Completed
40 enrolled
Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Phase 2 Completed
34 enrolled 10 charts
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2 Completed
13 enrolled 14 charts
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Phase 2 Completed
118 enrolled 14 charts
Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer
Phase 2 Completed
54 enrolled
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT
Phase 2 Completed
64 enrolled 17 charts
RIGHT Choice
Phase 2 Completed
222 enrolled 17 charts
COXEN
Phase 2 Completed
237 enrolled 20 charts
MIMIPAC
Phase 2 Completed
12 enrolled
SGI-110
Phase 2 Completed
120 enrolled 22 charts
Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma
Phase 2 Completed
40 enrolled
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
Phase 2 Completed
64 enrolled 10 charts
PATHFINDER
Phase 2 Completed
54 enrolled